Abstract
Human ζ-crystallin is a Zn2+-lacking medium-chain dehydrogenase/reductase (MDR) included in the quinone oxidoreductase (QOR) family because of its activity with quinones. In the present work a novel enzymatic activity was characterized: the double bond α,β- hydrogenation of medium-chain 2-alkenals and 3-alkenones. The enzyme is especially active with lipid peroxidation products such as 4-hydroxyhexenal, and a role in their detoxification is discussed. This specificity is novel in the QOR family, and it is similar to that described in the distantly related alkenal/one reductase family. Moreover, we report the X-ray structure of ζ-crystallin, which represents the first structure solved for a tetrameric Zn2+-lacking MDR, and which allowed the identification of the active-site lining residues. Docking simulations suggest a role for Tyr53 and Tyr59 in catalysis. The kinetics of Tyr53Phe and Tyr59Phe mutants support the implication of Tyr53 in binding/catalysis of alkenal/one substrates, while Tyr59 is involved in the recognition of 4-OH-alkenals. © 2010 Springer Basel AG.
Original language | English |
---|---|
Pages (from-to) | 1065-1077 |
Journal | Cellular and Molecular Life Sciences |
Volume | 68 |
DOIs | |
Publication status | Published - 1 Mar 2011 |
Keywords
- Alkenal/one reductase
- Double-bond α,β-hydrogenation
- Lipid peroxidation products
- Medium-chain dehydrogenases/reductases
- Quinone oxidoreductase